Nicholas Maestas
Director of Finance/CFO at TEMPEST THERAPEUTICS, INC.
Net worth: 6 570 $ as of 2024-06-29
Nicholas Maestas active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Director of Finance/CFO | 2021-07-11 | - |
| Corporate Secretary | 2022-09-29 | - |
Career history of Nicholas Maestas
Former positions of Nicholas Maestas
| Companies | Position | Start | End |
|---|---|---|---|
| ALECTOR, INC. | Corporate Officer/Principal | 2019-06-30 | 2021-06-30 |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 2014-10-31 | 2019-06-30 |
Training of Nicholas Maestas
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| University of California, Berkeley | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 1 |
| Corporate Secretary | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| TEMPEST THERAPEUTICS, INC. | Health Technology |
| ALECTOR, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
- Stock Market
- Insiders
- Nicholas Maestas
- Experience
